Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
07/2003
07/30/2003CN1116291C Substituted tetracyclic tetrahydrofuran derivatives
07/30/2003CN1116287C Diphenyl heterocycles as potassium channel modulators
07/30/2003CN1116060C Medicine for curing sleepless and brain trauma sequal
07/30/2003CN1116056C Health-care medicine for sobering up and eliminating alcoholism
07/30/2003CN1116040C Medicinal composition and its antalgic purpose
07/30/2003CN1116029C Tablet allowing prolonged release of sodium salt of tianeptine after administration by oral
07/29/2003WO2004065614A2 Suppression of cytotoxic protein conformers
07/29/2003US6600073 Sertraline hydrochloride Form III may be produced by heating sertraline hydrochloride Forms V and VI. Sertraline hydrochloride Forms V and VI may be produced from either sertraline hydrochloride or sertraline base by
07/29/2003US6600058 Vitamin D derivatives with carbo- or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments
07/29/2003US6600043 Carboxylic acid derivatives, their preparation and use
07/29/2003US6600038 Carbamoyl tetrahydropyridine derivatives
07/29/2003US6600036 Treating diseases of the central nervous system.
07/29/2003US6600027 Polynucleotide molecules encoding neospora proteins
07/29/2003US6599938 Optionally substituted Schiff base condensation products comprising an amino acid component and a benzaldehyde component, that have MIF (macrophage migration inhibitory factor) antagonist activity
07/29/2003US6599935 2-phenyl-1,3-propanediol dicarbamate derivatives used as antiepileptic and antiischemic agents
07/29/2003US6599932 Highly selective in killing tumor cells but not normal cells
07/29/2003US6599925 Cardiovascular disorders; anticancer agents
07/29/2003US6599916 Quinuclidine-substituted heteroaryl moieties for treatment of disease
07/29/2003US6599910 Substituted triazole compounds
07/29/2003US6599905 Pyrazine compounds
07/29/2003US6599904 Sulphonamide derivatives, process for their preparation, and their use as medicaments
07/29/2003US6599901 Pyridone substituted benzothiazole derivatives
07/29/2003US6599900 1-oxa-3,9-diaza-spiro[5,5]undecan-2-ones
07/29/2003US6599897 Quetiapine granules
07/29/2003US6599896 Use of tianeptine in the production of medicaments to treat neurodegenerative pathologies
07/29/2003US6599727 Human poly (ADP-ribose) polymerase 2 materials and methods
07/29/2003US6599695 Method for assaying for early gene expression in neuroblasts
07/29/2003US6599530 Oral compacted composition comprising catechol derivatives
07/29/2003US6599511 Pharmaceutical composition containing desoxypeganine for the treatment of drug dependence
07/29/2003US6599506 Inhibiting integrin-associated diseases; rejection of transplanted organs, allergies, and autoimmune diseases
07/29/2003CA2473102A1 Suppression of cytotoxic protein conformers
07/29/2003CA2269745C Improved treatment of migraine headache
07/29/2003CA2244621C 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide y receptor antagonists
07/29/2003CA2185036C Use of a non photosynthetic filamentous bacteria extract and composition containing the same
07/29/2003CA2180119C The composition containing snapping turtle and tortoise, the preparation and the use thereof
07/29/2003CA2102530C Therapeutic agent
07/29/2003CA2094280C A method for transplanting cells into the brain and therapeutic uses therefor
07/29/2003CA2066332C Substituted 3-(pyridinylamino)-indoles and benzo¬b|thiophenes, a process for their preparation and their use as medicaments
07/29/2003CA2048959C 3-(1,2-benzisoxazol-3-yl)-4-pyridinamines and derivatives
07/24/2003WO2003060525A1 Diagnostic and therapeutic use of the voltage-gated ion channel scn2a for neurodegenerative diseases
07/24/2003WO2003060521A2 Functional inactivation of cxcr4-mediated responses in growth hormone transgenic mice through socs3 upregulation
07/24/2003WO2003060475A2 Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1h-benzoimidazole analogues
07/24/2003WO2003060149A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
07/24/2003WO2003060142A2 Compositions and methods for controlled release
07/24/2003WO2003060091A2 Selective melanin-concentrating hormone type -1 receptor agonists
07/24/2003WO2003060085A2 Mammalian neural stem cells, compositions and uses thereof
07/24/2003WO2003060082A2 Use of modified pyrimidine compounds to promote stem cell migration and proliferation
07/24/2003WO2003059950A1 Ifnar2 mutants, their production and use
07/24/2003WO2003059921A1 Mmp inhibitors
07/24/2003WO2003059913A1 Roh-kinase inhibitors
07/24/2003WO2003059900A1 Coumarin derivatives, process for their production and use thereof
07/24/2003WO2003059899A1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof
07/24/2003WO2003059893A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
07/24/2003WO2003059891A1 Substituted pyridazinones as inhibitors of p38
07/24/2003WO2003059884A1 Modulators of lxr
07/24/2003WO2003059882A1 Phenoxy piperidines for treating diseases such as schizophrenia and depression
07/24/2003WO2003059880A1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these
07/24/2003WO2003059874A2 Aromatic thioether liver x-receptor modulators
07/24/2003WO2003059873A1 Potassium channel modulators
07/24/2003WO2003059871A1 N-alkylsulfonyl-substituted amide derivatives
07/24/2003WO2003059394A1 Composition for transporting oligonucleotides through the blood brain barrier and their use for treating central nervous system diseases
07/24/2003WO2003059386A2 Prion protein carrier-conjugates
07/24/2003WO2003059376A1 The use of il6r/il6 chimera in nerve cell regeneration
07/24/2003WO2003059372A2 Combined use of a glp-1 compound and a modulator of diabetic late complications
07/24/2003WO2003059365A1 Remedy for dysmnesia
07/24/2003WO2003059357A1 Pregnane steroids for use in the treatment of cns disorders
07/24/2003WO2003059349A1 Sedative non-benzodiazepine formulations
07/24/2003WO2003059348A1 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists
07/24/2003WO2003059346A1 Beta-secretase inhibitors
07/24/2003WO2003059345A1 Pharmaceutical compositions comprising valsartan and nep inhibitors
07/24/2003WO2003059344A1 Suppositories containing indole derivative
07/24/2003WO2003059341A1 1,3-disubstituted and 1,3,3,-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
07/24/2003WO2003059335A1 Phenyl sulfoxides and phenyl sulfones
07/24/2003WO2003059323A2 Stable salts of o-acetylsalicylic acid containing basic amino acids ii
07/24/2003WO2003059294A2 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor
07/24/2003WO2003059276A2 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof
07/24/2003WO2003059264A2 Methods for the induction of professional and cytokine-producing regulatory cells
07/24/2003WO2003059252A2 Use of a novel cell surface protease from group b streptococcus
07/24/2003WO2003047577A3 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses
07/24/2003WO2003045999A3 Human vanilloid receptor protein and polynucleotide sequence encoding same
07/24/2003WO2003032918A3 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors
07/24/2003WO2003032910A3 Carbinols for the treatment of neuropathic dysfunction
07/24/2003WO2003009741A3 Methods for treating joint inflammation, pain, and loss of mobility
07/24/2003WO2003004526B1 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or resistance to viruses and their use as medicines
07/24/2003WO2002102369A3 Agent for protection of retinal neurons
07/24/2003WO2002060942A3 Protein modification and maintenance molecules
07/24/2003WO2002049669A3 Electrically responsive promoter system
07/24/2003WO2002049575A3 Method and composition for the treatment of diabetic neuropathy
07/24/2003WO2002036634A3 Gene regulation therapy involving ferritin
07/24/2003US20030140360 Transgenic mammals and reagents for improving long-term memory
07/24/2003US20030139607 Antiarrhythmic agents, treating cardiovascular disorders, infarct prophylaxis, angina pectoris, shock, stroke, transplant organ surgery
07/24/2003US20030139602 Deetherification forming a 6-hydroxy-2-amide-alkyl-tetralin hydrochloride salt for treating Alzheimer's disease
07/24/2003US20030139597 Novel Cyclic hydroxamic acid as metalloproteinase inhibitors
07/24/2003US20030139590 Comprises nucleotide sequences coding orphan receptor 25 for detecting modulators of platelet activating factor (PAF) activity; antiinflammatory agents; gene/translation inhibition; drug screening
07/24/2003US20030139574 Active hedgehog protein conjugate
07/24/2003US20030139476 Method of treating chronic fatigue syndrome
07/24/2003US20030139472 Use of N-acetylcysteine for the preparation of a medicament suitable for the intravenous administration to prevent oxidative stress in dialysed patients
07/24/2003US20030139462 Antiinflammatory agents; autoimmune disease; antiarthritic agents
07/24/2003US20030139458 Stroke; Alzheimer's disease; Parkinson's disease; Huntington's disease
07/24/2003US20030139453 Difluorobutyric acid metalloprotease inhibitors
1 ... 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 ... 1833